HP Pyruvate MRI in Cancers

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 24, 2024

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2028

Conditions

ImageWarburg EffectTumors

Interventions

DRUG

Hyperpolarized 13C-Pyruvate

Imaging tumors pre and post administration of hyperpolarized 13-C pyruvate injection.

Trial Locations (1)

RECRUITING

University of Maryland Medical Center, Baltimore

All Listed Sponsors

lead

University of Maryland, Baltimore

OTHER